Atrial fibrillation (Afib) is the most common and underestimated cardiac arrhythmia with a lifetime risk of >35% after the age of 55 years and the risk continues to rise exponentially. Afib leads to stasis of blood within the atria allowing clot formation and increasing the risk for systemic embolization leading to strokes.

Learn how the Zio® ECG monitors helps track and detect irregular heart rhythms. Follow a simple process: wear the device, log symptoms with the My Zio® app, and return it by mail. Your doctor will review the results and create a care plan based on detailed heart data.

2020年11月30日 · The transatlantic clinical trial found that Zio by iRhythm, an ambulatory cardiac monitoring solution, led to a tenfold increase in the detection of atrial fibrillation (AF) versus patients receiving standard clinical care. One out of every 20 patients in the heart monitoring group was found to have a new diagnosis of atrial fibrillation and ...

Zio XT was associated with significantly higher documentation 1 of AF/AFL -related supraventricular tachycardias and non-sustained ventricular tachycardia than both 24-hour Holter and 30-day event monitoring.

In this pilot study, we examine a novel outpatient ambulatory cardiac rhythm monitoring device called the Zio® Patch (iRhythm Technologies, Inc., San Francisco, CA, USA), a single-use, noninvasive waterproof long-term continuous monitoring patch, capable of continuously monitoring for up to 14 days, and compare its use with that of the 24-hour H...

Wearables maker iRhythm Technologies on Monday released data suggesting its Zio patch increased the rate of atrial fibrillation (AFib) detection and reduced cardiac events, in results presented at the American Heart Association's annual scientific meeting.

Conclusion: Findings from the review suggest that long-term, continuous, uninterrupted monitoring with Zio results in longer patient wear times and higher cardiac arrhythmia detection rates compared with outcomes reported in previous reviews of short-duration (24-48 h) cardiac rhythm recording studies.

2022年7月22日 · The Zio Watch builds on that work evolving to a FDA-cleared prescription-based wrist-worn solution that can detect irregular rhythms indicative of AFib and with the ZEUS System can characterize the amount of AFib over time, thus aiding a clinician in diagnosis.

2022年4月4日 · In the Rutgers-TAVR study, iRhythm reported that monitoring with Zio AT post-TAVR discharge can identify AFib, high-degree atrioventricular block (HAVB) and supraventricular tachycardia (SVT)...

2018年7月17日 · The Zio patch is a 2-by-5-inch adhesive patch, much like a bandage, and is worn on the upper left side of the chest. It’s water resistant and can be kept on even while a person exercises or takes a shower.